The use of uric acid in the treatment of multiple sclerosis

被引:0
|
作者
Koprowski, Hilary [1 ]
机构
[1] Thomas Jefferson Univ, Ctr Neurovirol, Inst Biotechnol & Adv Mol Med, Philadelphia, PA 19107 USA
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:35 / 36
页数:2
相关论文
共 50 条
  • [21] Variation of serum uric acid levels in multiple sclerosis during relapses and immunomodulatory treatment
    Guerrero, A. L.
    Martin-Polo, J.
    Laherran, E.
    Gutierrez, F.
    Iglesias, F.
    Tejero, M. A.
    Rodriguez-Gallego, M.
    Alcazar, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (04) : 394 - 397
  • [22] Does an increasing of serum uric acid levels have therapeutic value in the treatment of multiple sclerosis?
    Toncev, G
    Milicic, B
    Toncev, S
    NEUROLOGY, 2004, 62 (07) : A492 - A492
  • [23] Uric acid levels in sera from patients with multiple sclerosis
    Jelena Drulović
    Irena Dujmović
    Nebojša Stojsavljević
    Šarlota Mesaroš
    Slobodanka Andjelković
    Djordje Miljković
    Vesna Perić
    Gradimir Dragutinović
    Jelena Marinković
    Zvonimir Lević
    Marija Mostarica Stojković
    Journal of Neurology, 2001, 248 : 121 - 126
  • [24] Uric acid: a potential biomarker of multiple sclerosis and of its disability
    Moccia, Marcello
    Lanzillo, Roberta
    Palladino, Raffaele
    Russo, Cinzia
    Carotenuto, Antonio
    Massarelli, Marco
    Vacca, Giovanni
    Vacchiano, Veria
    Nardone, Antonio
    Triassi, Maria
    Morra, Vincenzo Brescia
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (05) : 753 - 759
  • [25] Serum uric acid level in Iranian patients with multiple sclerosis
    Mamarabadi, M.
    Razjouyan, H.
    Moghaddasi, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 224 - 224
  • [26] Uric acid levels in sera from patients with multiple sclerosis
    Drulovic, J
    Dujmovic, I
    Stojsavljevic, N
    Mesaros, S
    Andjelkovic, S
    Miljkovic, D
    Peric, V
    Dragutinovic, G
    Marinkovic, J
    Levic, Z
    Stojkovic, MM
    JOURNAL OF NEUROLOGY, 2001, 248 (02) : 121 - 126
  • [27] Increase in serum levels of uric acid, an endogenous antioxidant, under treatment with glatiramer acetate for multiple sclerosis
    Constantinescu, CS
    Freitag, P
    Kappos, L
    MULTIPLE SCLEROSIS, 2000, 6 (06): : 378 - 381
  • [28] The use of valproic acid and multiple sclerosis
    Nielsen, N. M.
    Svanstrom, H.
    Stenager, E.
    Magyari, M.
    Koch-Henriksen, N.
    Pasternak, B.
    Hviid, A.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 226 - 226
  • [29] The use of valproic acid and multiple sclerosis
    Nielsen, Nete Munk
    Svanstrom, Henrik
    Stenager, Egon
    Magyari, Melinda
    Koch-Henriksen, Nils
    Pasternak, Bjorn
    Hviid, Anders
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 (03) : 262 - 268
  • [30] Serum and cerebrospinal fluid uric acid levels in multiple sclerosis patients
    Zamani, Alireza
    Rezaei, Aliakbar
    Khaeir, Fatemeh
    Hooper, D. Craig
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2008, 110 (06) : 642 - 643